Anticoagulation for elderly patients with atrial fibrillation: Not to be neglected

Europace

Volumn 10, Issue 1, 2008, Pages 1-2

  Taggar, Jaspal S ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; WARFARIN; ANTICOAGULANT AGENT;

AGED; AGING; ANTICOAGULATION; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STROKE; TRANSIENT ISCHEMIC ATTACK; AGE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; INTRACRANIAL HEMORRHAGES; RISK FACTORS; STROKE;

EID: 40349108814     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum223     Document Type: Editorial

References (20)

1. Sudlow M, Thompson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998;352:1167-71.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JE et al. Prevalence of diagnosed atrial fibrillation in adults. national implications for rhythm management and stroke prevention: the AnTicoagualtion and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370- 5.
3. Stewart S, Murphy N, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004;90:286-92.
4. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007;69:546-54.
5. National Collaborating Centre for Chronic Conditions. Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care. London: Royal College of Physicians; 2006.
6. Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 2006;118:321-33.
7. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67.
8. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-6.
9. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Ann Intern Med 1999;131:927-34.
10. Hylek EM, D'Antonio J, Evans-Molina C, Shea C, Henault LE, Regan S. Translating the results of randomised trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. Stroke 2006;37:1075-80.
11. Derevereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation. BMJ 2001;323:1-7.
12. Man-Son-Hing M, Laupacis A. Anticoagulation-related bleeding in older persons with atrial fibrllation. Arch Intern Med 2003;163:1580-6.
13. Lip GY, Zarifis J, Watson RD, Beevers DG. Physician variation in the management of patients with atrial fibrillation. Heart. 1996;75:200-5.
14. Lackie CL, Garbarino KA, Pruetz JA. Warfarin therapy for atrial fibrillation in the elderly. Ann Pharmacother 2002;36:200-4.
15. Fang M, Chen J, Rich MW. Atrial fibrillation in the elderly. Am J Med 2007;120:481-7.
16. Fang MC, Chang YC, Hylek EM, Rosand J, Greenberg SM, Go AS et al. Advanced age, anticoagulation intensity, and risk for intracranial haemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004;141:745-52.
17. Torn M, Bollen WL, Van der Meer FJ, Van der Wall EE, Rosendaal FR. Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 2005;165:1527-32.
18. Copland M, Walker ID, Campbell Tait R. Oral anticoagulation and hemorrhagic complications in an elderly populaton with atrial fibrillation. Arch Intern Med 2001;161:2125-8.
19. Mant J, Hobbs R, Fletcher K, Roalfe A, Fitzmaurice D, Lip GYH et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503.
20. Lip GY, Frison L, Grind M; SPORTIF Invetigators. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J 2007;28:752-9.